Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
7.57
+0.37 (5.14%)
At close: Oct 7, 2025, 4:00 PM EDT
7.88
+0.31 (4.10%)
After-hours: Oct 7, 2025, 7:34 PM EDT
Personalis Market Cap
Personalis has a market cap or net worth of $671.29 million as of October 7, 2025. Its market cap has increased by 99.66% in one year.
Market Cap
671.29M
Enterprise Value
541.32M
1-Year Change
99.66%
Ranking
Category
Stock Price
$7.57
Market Cap Chart
Since June 20, 2019, Personalis's market cap has decreased from $847.61M to $671.29M, a decrease of -20.80%. That is a compound annual growth rate of -3.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 638.47M | 55.54% |
| Dec 31, 2024 | 410.49M | 298.67% |
| Dec 29, 2023 | 102.97M | 13.12% |
| Dec 30, 2022 | 91.02M | -85.76% |
| Dec 31, 2021 | 639.07M | -55.16% |
| Dec 31, 2020 | 1.43B | 318.66% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |